title: Reprogramming of round spermatids by the germinal vesicle cytoplasm in mice.
abstract: The birthrate following round spermatid injection (ROSI) remains low in current and evidence suggests that factors in the germinal vesicle (GV) cytoplasm and certain substances in the GV such as the nucleolus might be responsible for genomic reprogramming and embryonic development. However, little is known whether the reprogramming factors in GV oocyte cytoplasm and/or nucleolus in GV are beneficial to the reprogramming of round spermatids and development of ROSI embryos. Here, round spermatids were treated with GV cytolysates and injected this round spermatid alone or co-injected with GV oocyte nucleolus into mature metaphase II oocytes. Subsequent embryonic development was assessed morphologically and by Oct4 expression in blastocysts. There was no significant difference between experimental groups at the zygote to four-cell development stages. Blastocysts derived from oocytes which were injected with cytolysate treated-round spermatid alone or co-injected with nucleoli injection yielded 63.6% and 70.3% high quality embryos, respectively; comparable to blastocysts derived by intracytoplasmic sperm injection (ICSI), but higher than these oocytes which were co-injected with lysis buffer-treated round spermatids and nucleoli or injected with the lysis buffer-treated round spermatids alone. Furthermore, the proportion of live offspring resulting from oocytes which were co-injected with cytolysate treated-round spermatids and nucleoli or injected with cytolysate treated-round spermatids alone was higher than those were injected with lysis buffer treated-round spermaids, but comparable with the ICSI group. Our results demonstrate that factors from the GV cytoplasm improve round spermatid reprogramming, and while injection of the extra nucleolus does not obviously improve reprogramming its potential contribution, although which cannot be definitively excluded. Thus, some reprogramming factors are evidently present in GV oocyte cytoplasm and could significantly facilitate ROSI technology, while the nucleolus in GV seems also having a potential to improve reprogramming of round spermatids.
authors.affiliation: Department of Laboratory Animal Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
authors.forename: Peng-Cheng
authors.initials: PC
authors.lastname: Kong
authors.forename: Yan
authors.initials: Y
authors.lastname: Zhu
authors.forename: Mei-Shan
authors.initials: MS
authors.lastname: Wang
authors.forename: He-Ping
authors.initials: HP
authors.lastname: Li
authors.forename: Xue-Jin
authors.initials: XJ
authors.lastname: Chen
authors.forename: Man-Xi
authors.initials: MX
authors.lastname: Jiang
mesh_terms: D000818:Animals; D001755:Blastocyst / Q000166:cytology / Q000378:metabolism; D002466:Cell Nucleolus / Q000378:metabolism* / Q000637:transplantation*; D003593:Cytoplasm / Q000378:metabolism*; D005260:Female; D008297:Male; D051379:Mice; D050814:Octamer Transcription Factor-3 / Q000096:biosynthesis; D009865:Oocytes / Q000166:cytology / Q000378:metabolism; D020554:Sperm Injections, Intracytoplasmic; D013087:Spermatids / Q000166:cytology / Q000378:metabolism
chemical_list: D050814:Octamer Transcription Factor-3; C494174:Pou5f1 protein, mouse